Navigation Links
Valopicitabine in Medical News

Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results

...V), respectively, and the amortization of the up-front fees received by Idenix in connection with Novartis' license of telbivudine, valtorcitabine and valopicitabine and product sales of Tyzeka/Sebivo. Idenix reported a net loss of $30.5 million, or a loss of $0.54 per basic and diluted share for the third quarter ...
Valopicitabine in Medical Technology

Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver

Additional Preclinical Data Presented on Valopicitabine Combined with an Investigational Protease Inhibitor BARCELONA, Spain, April 12, 2007 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. today announced results from two phase IIb studies of the novel combination of valopicitabine (NM283) ...

Idenix Announces Data Presentations at the 2007 Digestive Disease Week Meeting

...ster session beginning on Monday, May 21, 2007 at 8:00 a.m. EDT. About valopicitabine (NM283) valopicitabine is an investigational HCV RNA polymerase inhibitor being evaluated in ongoi...

Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial

... ~ valopicitabine achieved both primary and secondary endpoints of s...s. Patients in arm A (n=39) received 200 mg/day of valopicitabine and pegylated interferon alpha 2a; patients in arm...day lead-in period, where patients received either valopicitabine or placebo alone; the additional components of eac...
Valopicitabine in Biological News

Novel therapy combinations gain ground in treating hepatitis

... lead to more significant breakthroughs and relief for these patients." valopicitabine (NM283), Alone or with Peg-Interferon, Compared to Peg Interferon/Ribavirin...nts in patients who have not experienced remission with standard therapies: valopicitabine alone (800 mg/d), one of three combination arms with the drug at 400 mg/d, ...
Other Tags
(Date:7/10/2014)... to 70% of Parkinson,s disease (PD) patients experience ... life. Some patients have disturbed sleep/wake patterns such ... other patients may be subject to sudden and ... patients may exhibit REM-sleep behavior disorder (RBD), characterized ... before motor symptoms appear. A review in the ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... research review identifying the clinical indicators most strongly associated ... process of developing evidence-based guidelines for concussion diagnosis, prognosis, ... Neurosurgery , official journal of the ... is published by Lippincott Williams & Wilkins , ... , Based on analysis of the best available ...
(Date:7/10/2014)... Harbor, NY For decades, health-conscious people around the ... in antioxidants, figuring this was one of the paths ... , Yet clinical trials of antioxidant supplements have repeatedly ... to reduce their cancer risk. Virtually all such ... cancer. In fact, in several trials antioxidant supplementation ...
(Date:7/10/2014)... Biomedical Research Institute (IDIBELL) and the Catalan Institute of ... new therapeutic combination to combat resistant sarcomas. The clinical ... stabilize the growth of these tumors have been published ... ., Sarcomas , Sarcomas are a rare type ... It can affect from children to older ages. It ...
Breaking Medicine News(10 mins):Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:How antioxidants can accelerate cancers, and why they don't protect against them 2Health News:New therapeutic combination to slow resistant sarcomas 2
(Date:7/10/2014)... yellow crazy ant Anoplolepis gracilipes is ranked amongst ... for catastrophic ecological impacts on islands. A new study published ... examines and assesses the effects and dangers of the introduction ... the mature palm forest of the Valle de Mai, a ... forest of Valle de Mai is a unique ecosystem containing ...
(Date:7/10/2014)... the West African nation Burkina Faso today have ... Press has the potential to increase access to ... and in communities by combining a lower-dose formulation ... acetate)with the BD Uniject injection system. , Burkina ... expected to begin introducing Sayana Press in 2014, ...
(Date:7/9/2014)... pivotal in the development of cancer, viral infection and ... question about one of the most widely-researched proteins in ... of thousands of research papers and millions of pounds ... in Professor Sir Philip Cohen,s laboratory at the University ... is activated. The results are published today ...
Breaking Biology News(10 mins):Invasion of yellow crazy ant in a Seychelles UNESCO palm forest: Threats and solutions 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3Research reveals how key controller protein is switched on 2
Other Contents